Arcutis Biotherapeutics, Inc. (ARQT) — SC 13D/A Filings
All SC 13D/A filings from Arcutis Biotherapeutics, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Frazier Life Sciences updates Arcutis Biotherapeutics stake
— Mar 6, 2024 Risk: medium
Frazier Life Sciences VIII, L.P. and its affiliates, including James N. Topper and Patrick J. Heron, have amended their Schedule 13D filing regarding Arcutis Bi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX